LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EU biotech and biomanufacturing Initiative: Key asks for Industrial Biotechnology

08/02/2024
POSITION PAPER

The EU biotech and biomanufacturing initiative is a unique opportunity for the EU to take urgent and immediate actions to support the scale up of the EU biotech and biomanufacturing sector. This must be coupled with a regulatory environment that encourages investments in research and development, fosters innovation and market access. The EU must also provide incentives that attract the best in class for skills, in both business and biomanufacturing.

Building on its strong science and research base, and the EU Commission’s recent announcements on its ambition for European leadership in new technologies, Europe now needs to create impact from these good intentions and to reinforce its competitiveness.

We have identified specific key asks for a globally competitive EU Industrial biotechnology sector that delivers sustainable innovative solutions.

  1. Need for harmonised national and EU frameworks for enabling biotechnology;
  2. Address regulatory hurdles to accelerate market access and enhance global competitiveness;
  3. Improve access to feedstock and recognition of sustainability;
  4. Support infrastructure scale up and improve access to skills.

We call on these specific key asks to be considered in the forthcoming European Commission Biotechnology and Biomanufacturing initiative alongside 5 common cross-sectoral principles.

EU biotech and biomanufacturing Initiative: Key asks for Industrial Biotechnology


Download

Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
21/05/2025

Ensuring Biotech Integration in the Single Market


Read more
16/04/2025

EuropaBio position on the EU Life Sciences Strategy


Read more

Important links

  • Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World
  • Ensuring Biotech Integration in the Single Market

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.